Your browser doesn't support javascript.
loading
Successful Management of Checkpoint Inhibitor-Induced Arthritis With Disease-Modifying Antirheumatic Drugs During Active Immune Checkpoint Inhibition Treatment.
Brynjarsdottir, Helga B; Bjursten, Sara; Levin, Max; Gjertsson, Inger; Rudin, Anna.
Affiliation
  • Brynjarsdottir HB; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg; helga.bjork.brynjarsdottir@gu.se.
  • Bjursten S; Department of Rheumatology, Sahlgrenska University Hospital.
  • Levin M; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg.
  • Gjertsson I; Department of Oncology, Sahlgrenska University Hospital.
  • Rudin A; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg.
J Rheumatol ; 50(9): 1195-1197, 2023 09.
Article in En | MEDLINE | ID: mdl-37003605
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents Limits: Humans Language: En Journal: J Rheumatol Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Rheumatoid / Antirheumatic Agents Limits: Humans Language: En Journal: J Rheumatol Year: 2023 Document type: Article